May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Neuroprotective Effect of Ginexin (Ginko Biloba Extract) on Rat Retinal Ganglion Cell in Optic Nerve Crush Injury Model
Author Affiliations & Notes
  • J.H. Kang
    Dept Ophthalmology, Inje Univ Seoul Paik Hosp, Seoul, Republic of Korea
  • K.H. Park
    Dept Ophthalmology, Seoul National University College of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • Y.J. Kim
    Dept Ophthalmology, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • J.H. Kim
    Life Science Research and Development Center, SK chemical, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  J.H. Kang, None; K.H. Park, None; Y.J. Kim, None; J.H. Kim, SK Chemical E.
  • Footnotes
    Support  SK Chemical
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 130. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      J.H. Kang, K.H. Park, Y.J. Kim, J.H. Kim; The Neuroprotective Effect of Ginexin (Ginko Biloba Extract) on Rat Retinal Ganglion Cell in Optic Nerve Crush Injury Model . Invest. Ophthalmol. Vis. Sci. 2003;44(13):130.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To investigate the neuroprotective effect of Ginexin (Ginkgo biloba extract) on rat retinal ganglion cells in an optic nerve crush injury model. Methods:From one week before the optic nerve injury, Ginexin 100mg/kg/day (100mg group), 200mg/kg/day (200mg group) or the vehicle, carboxymethylcellulose, as a control group (CMC group) was administrated orally for 4 weeks in Spraque-Dawley rats. Three weeks after the optic nerve injury, the retrograde labeling of the retinal ganglion cells (RGCs) was accomplished by dextran tetramethylrhodamine. The labeled RGCs were counted using fluorescence microscopy. The vitreous was separated at the time of enucleation and the intravitreal glutamate concentration was measured. Results:The RGC density of the CMC group (103 ± 22 cells/mm2 , n=10) was significantly lower than that of the 100mg (182 ± 39 cells/mm2, n=10) and the 200 mg group (201 ± 63 cells/mm2, n=7) (p<0.01). The RGC density of the 100mg group and 200mg group was similar. The normal RGC density was 1.185 ± 168/mm2. The invtravitreal glutamate concentration in the normal (792 ± 226 pmol/µl), the CMC group (971 ± 335 pmol/µl;), the 100mg group (884 ± 199 pmol/µl;) and the 200mg group (875 ± 134 pmol/µl) was similar (p>0.05). Conclusions:Ginexin increased the survival of the retinal ganglion cell in the rat optic nerve crush injury model. However, it did not significantly influence the intravitreal glutamate concentration.

Keywords: ganglion cells • neuroprotection • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×